Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Intec Pharma Ltd. | 40,000 | reported | 15 Jul 2020 | tx 2+140,000 |
| Travere Therapeutics, Inc. | 29,000 | reported | 08 May 2019 | tx 10+105,000 |
| QLT INC/BC | 28,400 | reported | 17 Jun 2016 | tx 26+172,400−37,000 |
| Corium International, Inc. | 12,000 | reported | 04 Dec 2014 | tx 1+12,000 |
| LIGAND PHARMACEUTICALS INC | 0 | reported | 13 May 2026 | tx 180+318,576−90,050 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 80 | 227.37 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1 | 229.87 USD | 10b5-1anomaly |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 165 | 231.87 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 105 | 232.57 USD | 10b5-1 |
| 01 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 116 | 234.09 USD | 10b5-1 |
| 12 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 459 | 69.51 USD | 10b5-1 |
| 12 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 459 | 224.00 USD | 10b5-1 |
| 13 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 1,575 | 69.51 USD | 10b5-1 |
| 13 May 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1,575 | 223.50 USD | 10b5-1 |
| 12 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 459 | 0.00 USD | 10b5-1deriv |
| 13 May 2026 | EXERCISE | LIGAND PHARMACEUTICALS INC | 1,575 | 0.00 USD | 10b5-1deriv |
| 02 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 42 | 203.57 USD | |
| 02 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 50 | 202.54 USD | |
| 02 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 83 | 201.65 USD | |
| 02 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 204 | 199.69 USD | |
| 02 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 47 | 197.14 USD | |
| 02 Mar 2026 | SALE | LIGAND PHARMACEUTICALS INC | 41 | 200.40 USD | |
| 02 Feb 2026 | SALE | LIGAND PHARMACEUTICALS INC | 23 | 195.61 USD | |
| 02 Feb 2026 | SALE | LIGAND PHARMACEUTICALS INC | 23 | 197.20 USD | |
| 02 Feb 2026 | SALE | LIGAND PHARMACEUTICALS INC | 381 | 196.36 USD | |
| 02 Feb 2026 | SALE | LIGAND PHARMACEUTICALS INC | 39 | 191.00 USD | |
| 02 Feb 2026 | SALE | LIGAND PHARMACEUTICALS INC | 1 | 192.18 USD | anomaly |
| 02 Jan 2026 | SALE | LIGAND PHARMACEUTICALS INC | 21 | 186.59 USD | |
| 02 Jan 2026 | SALE | LIGAND PHARMACEUTICALS INC | 207 | 190.27 USD | |
| 02 Jan 2026 | SALE | LIGAND PHARMACEUTICALS INC | 46 | 192.40 USD |
4 purchases reported after at least 12 months of silence — most recent on 23 Aug 2019.